HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Raimonda Kubiliute Selected Research

tetraphenylphosphonium (tetraphenylphosphonium chloride)

1/2021Nongenotoxic ABCB1 activator tetraphenylphosphonium can contribute to doxorubicin resistance in MX-1 breast cancer cell line.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Raimonda Kubiliute Research Topics

Disease

2Neoplasms (Cancer)
08/2021 - 01/2021
1Renal Cell Carcinoma (Grawitz Tumor)
08/2021
1Breast Neoplasms (Breast Cancer)
01/2021

Drug/Important Bio-Agent (IBA)

1MicroRNAs (MicroRNA)IBA
08/2021
1Nucleic AcidsIBA
08/2021
1Biomarkers (Surrogate Marker)IBA
08/2021
1ATP-Binding Cassette Transporters (ABC Transporters)IBA
01/2021
1tetraphenylphosphonium (tetraphenylphosphonium chloride)IBA
01/2021
1Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021